deCode Genetics

Acquired

24front

Reykjavik, Iceland · Founded 1996 · $173.0M raised

Headquarters
Reykjavik
Employees
201–500
Founded
1996
Business Model
B2B
Website
decode.com
Total Funding
$173.0M
Last Round
$173.0M Venture RoundJul 2000
Rounds
1
Acquisition Date
Dec 2012

About

deCODE genetics, an Amgen subsidiary headquartered in Reykjavik, Iceland, is a global leader in analyzing the human genome to identify genetic risk factors for common diseases. Using Iceland's unique population genetics resources, deCODE has discovered risk factors for dozens of conditions including cardiovascular disease, cancer, and neurological disorders, advancing drug discovery and development.

Summary

deCode Genetics is a Biotech company based in Reykjavik, Iceland, founded in 1996. It has raised $173.0M in total across 1 round, most recently a $173.0M Venture Round round in Jul 2000. Investors include Amgen, ARCH Venture Partners and Polaris Partners.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionDec 2012
$415.0M

Sign up to see all 2 rounds

Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

deCode Genetics on Indexed.vc
<a href="https://indexed.vc/companies/decode-genetics"><img src="https://indexed.vc/api/badge/company/decode-genetics" alt="deCode Genetics on Indexed.vc" width="260" height="76" /></a>